Biotest AG (Biotest AG) Accounts Payable : $83.9 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biotest AG Accounts Payable?

Biotest AG's Accounts Payable for the quarter that ended in Mar. 2024 was $83.9 Mil.

Biotest AG's quarterly Accounts Payable increased from Sep. 2023 ($56.9 Mil) to Dec. 2023 ($85.2 Mil) but then declined from Dec. 2023 ($85.2 Mil) to Mar. 2024 ($83.9 Mil).

Biotest AG's annual Accounts Payable increased from Dec. 2021 ($43.8 Mil) to Dec. 2022 ($54.1 Mil) and increased from Dec. 2022 ($54.1 Mil) to Dec. 2023 ($85.2 Mil).

Biotest AG Accounts Payable Historical Data

The historical data trend for Biotest AG's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Accounts Payable Chart

Biotest AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

58.00

51.10

43.84

54.13

85.17

Biotest AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															47.86	59.05	56.88	85.17	83.91

Biotest AG Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Biotest AG Accounts Payable Related Terms

Thank you for viewing the detailed overview of Biotest AG's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG (Biotest AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (OTCPK:BIESF) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

BIO3:Germany BIO3:Austria

Address

Landsteinerstrasse 5, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.